bf/NASDAQ:PDSB_icon.jpeg

NASDAQ:PDSB

PDS Biotechnology Corporation

  • Stock

USD

Last Close

3.94

26/07 20:00

Market Cap

129.11M

Beta: 1.87

Volume Today

141.71K

Avg: 364.73K

PE Ratio

−3.04

PFCF: −5.01

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
1.57M
-
2.32M
47.80%
3.03M
30.78%
3.92M
29.48%
2.38M
39.18%
798.58K
66.51%
1.31M
63.60%
1.36M
4.27%
1.26M
7.19%
average receivables
229.51K
-
book value per share
-20.32
-
-36.85
81.33%
302.87
921.92%
61.86
79.58%
41.04
33.65%
19.10
53.46%
2.40
87.42%
1.62
32.58%
2.47
52.42%
1.54
37.70%
capex per share
-0.18
-
-1.17
546.33%
-3.23
175.51%
-0.48
85.26%
-0.12
73.90%
capex to depreciation
-30.80
-
-28.33
8.02%
-24.57
13.28%
-6.86
72.08%
-1.03
84.96%
capex to operating cash flow
0.02
-
0.09
435.21%
0.06
34.12%
0.02
64.44%
0.00
78.26%
capex to revenue
cash per share
10.40
-
18.18
74.71%
321.94
1,671.26%
73.72
77.10%
57.95
21.39%
22.18
61.73%
2.50
88.74%
1.72
31.06%
2.55
47.99%
2.58
1.27%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.16
-
0.04
75.89%
0.13
241.32%
0.22
63.84%
0.02
-
0.01
63.06%
0.30
4,077.12%
debt to equity
-0.10
-
0.04
143.10%
0.17
287.31%
0.33
95.83%
0.02
-
0.01
65.51%
0.53
6,776.59%
dividend yield
earnings yield
-0.04
-
-0.07
77.27%
-0.28
278.26%
-0.11
61.26%
-0.18
65.98%
-4.08
2,181.86%
-0.54
86.69%
-0.41
23.63%
-0.08
80.31%
-0.11
32.63%
-0.28
157.94%
enterprise value
158.32M
-
155.24M
1.94%
-23.79M
115.33%
269.36M
1,232.04%
217.18M
19.37%
-24.62M
111.33%
738.67K
103.00%
7.61M
929.56%
142.58M
1,774.86%
327.16M
129.45%
enterprise value over ebitda
-24.43
-
-11.80
51.72%
0.84
107.11%
-6.83
913.81%
-4.24
37.93%
0.84
119.82%
-0.04
105.26%
-0.51
1,061.18%
-6.65
1,197.35%
-8.03
20.73%
ev to operating cash flow
-19.68
-
-15.98
18.80%
1.09
106.85%
-8.37
865.02%
-5.34
36.23%
0.74
113.91%
-0.04
105.50%
-0.58
1,315.13%
-11.42
1,874.42%
-12.73
11.43%
ev to sales
free cash flow per share
-10.83
-
-14.03
29.56%
-57.02
306.31%
-22.78
60.05%
-26.90
18.11%
-21.22
21.11%
-3.71
82.51%
-0.79
78.85%
-0.49
37.88%
-0.90
84.29%
free cash flow yield
-0.05
-
-0.06
29.56%
-0.23
257.55%
-0.09
60.05%
-0.14
57.56%
-3.31
2,202.70%
-1.40
57.62%
-0.37
73.81%
-0.06
83.59%
-0.07
13.09%
graham net net
-21.02
-
-41.24
96.16%
293.21
810.98%
58.73
79.97%
38.05
35.22%
18.09
52.44%
1.92
89.36%
1.50
22.17%
2.39
59.78%
1.43
40.36%
graham number
64.55
-
115.73
79.29%
687.86
494.39%
193.49
71.87%
175.80
9.14%
106.04
39.68%
8.82
91.69%
5.69
35.51%
6.06
6.59%
7.03
16.04%
income quality
1.17
-
0.80
31.88%
0.77
2.70%
0.83
7.03%
0.80
3.50%
0.81
1.38%
2.58
218.34%
0.89
65.71%
0.74
16.67%
0.63
14.73%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-1.93K
-
-72.03
96.28%
-32.45
54.94%
-32.83
1.15%
-23.84
27.39%
-30.24
26.86%
-626.80
1,972.89%
-31.65
-
-10.23
67.67%
interest debt per share
0.00
-
3.94
88,633.75%
15.12
283.66%
11.20
25.94%
14.90
33.06%
0.91
93.88%
0.01
99.24%
0.04
428.66%
0.02
47.44%
0.87
4,424.74%
inventory turnover
invested capital
-0.10
-
0.04
143.10%
0.17
287.31%
0.33
95.83%
0.02
-
0.01
65.51%
0.53
6,776.59%
market cap
166.18M
-
166.18M
0%
101.10M
39.16%
360.80M
256.88%
284.79M
21.07%
10.03M
96.48%
12.90M
28.63%
35.83M
177.78%
207.34M
478.60%
377.51M
82.08%
153.83M
59.25%
net current asset value
-15.55M
-
-29.44M
89.27%
119.66M
506.46%
85.72M
28.36%
58.80M
31.40%
29.27M
50.23%
11.68M
60.11%
26.58M
127.60%
62.85M
136.50%
43.47M
30.83%
net debt to ebitda
1.21
-
0.83
31.47%
4.40
429.76%
2.32
47.36%
1.32
43.09%
1.18
10.38%
0.73
38.49%
1.90
161.79%
3.02
58.73%
1.24
59.09%
net income per share
-9.11
-
-16.15
77.27%
-69.43
329.85%
-26.90
61.26%
-33.47
24.42%
-26.16
21.83%
-1.44
94.50%
-0.89
38.32%
-0.66
25.46%
-1.43
116.13%
-1.39
2.88%
operating cash flow per share
-10.65
-
-12.86
20.76%
-53.79
318.22%
-22.30
58.54%
-26.78
20.07%
-21.22
20.75%
-3.71
82.51%
-0.79
78.85%
-0.49
37.88%
-0.90
84.29%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.79
-
-0.72
9.18%
-0.21
70.74%
-0.35
67.15%
-0.55
56.89%
-1.13
105.47%
-0.48
57.20%
-0.48
0.48%
-0.25
47.62%
-0.53
110.72%
revenue per share
roe
0.45
-
0.44
2.24%
-0.23
152.30%
-0.43
89.67%
-0.82
87.53%
-1.37
67.96%
-0.60
56.32%
-0.55
8.53%
-0.27
51.09%
-0.93
246.90%
roic
0.40
-
0.50
26.82%
-0.20
139.70%
-0.36
81.38%
-0.60
64.98%
-1.35
126.49%
-1.71
26.10%
-0.53
69.17%
-0.26
49.85%
-0.60
126.08%
sales general and administrative to revenue
shareholders equity per share
-20.32
-
-36.85
81.33%
302.87
921.92%
61.86
79.58%
41.04
33.65%
19.10
53.46%
2.40
87.42%
1.62
32.58%
2.47
52.42%
1.54
37.70%
stock based compensation to revenue
tangible asset value
-15.35M
-
-27.83M
81.33%
122.48M
540.03%
89.28M
27.11%
62.37M
30.14%
29.84M
52.16%
11.70M
60.80%
27.13M
131.92%
63.21M
132.99%
44.00M
30.39%
tangible book value per share
-20.32
-
-36.85
81.33%
302.87
921.92%
61.86
79.58%
41.04
33.65%
19.10
53.46%
2.40
87.42%
1.62
32.58%
2.47
52.42%
1.54
37.70%
working capital
6.74M
-
11.55M
71.31%
122.68M
962.28%
100.67M
17.94%
76.19M
24.32%
29.27M
61.58%
11.68M
60.11%
27.07M
131.80%
63.08M
133.07%
66.66M
5.67%

All numbers in USD (except ratios and percentages)